Not yet recruiting
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
NCT07814001
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- Hopital Henri Mondor Créteil, France
- Chu Dijon Bourgogne Dijon, France
- Chu de Lille - Hopital Claude Huriez Lille, France
- CHU de Limoges - Hopital Dupuytren Limoges, France